Hoth Net Invested Capital from 2010 to 2024
| HOTH Stock | USD 1.18 0.05 4.07% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 8.8 M | Current Value 5.1 M | Quarterly Volatility 3 M |
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth main balance sheet or income statement drivers, such as Interest Income of 742, Interest Expense of 368.8 K or Selling General Administrative of 4.5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.53. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
Hoth | Net Invested Capital |
Latest Hoth Therapeutics' Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of Hoth Therapeutics over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Hoth Therapeutics' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hoth Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
| Timeline |
Hoth Net Invested Capital Regression Statistics
| Arithmetic Mean | 3,036,654 | |
| Geometric Mean | 1,898,809 | |
| Coefficient Of Variation | 99.36 | |
| Mean Deviation | 2,445,537 | |
| Median | 1,184,293 | |
| Standard Deviation | 3,017,229 | |
| Sample Variance | 9.1T | |
| Range | 9.7M | |
| R-Value | 0.74 | |
| Mean Square Error | 4.5T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 497,044 | |
| Total Sum of Squares | 127.5T |
Hoth Net Invested Capital History
About Hoth Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Hoth Therapeutics income statement, its balance sheet, and the statement of cash flows. Hoth Therapeutics investors use historical funamental indicators, such as Hoth Therapeutics's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics investors may use each financial statement separately, they are all related. The changes in Hoth Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hoth Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hoth Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hoth Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Invested Capital | 8.8 M | 5.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Hoth Therapeutics Correlation against competitors. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.